Cargando…
Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data
BACKGROUND: Ablation-based treatment has emerged as an alternative rhythm control strategy for symptomatic atrial fibrillation (AF). Recent studies have demonstrated the cost-effectiveness of ablation compared with medical therapy in various circumstances. We assessed the economic comparison between...
Autores principales: | Kim, Woojin, Kim, Min, Kim, Yun Tae, Park, Woongbi, Kim, Jin-bae, Kim, Changsoo, Joung, Boyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902500/ https://www.ncbi.nlm.nih.gov/pubmed/36760559 http://dx.doi.org/10.3389/fcvm.2023.1062578 |
Ejemplares similares
-
Cost-Effectiveness of Rate- and Rhythm-Control Drugs for Treating Atrial Fibrillation in Korea
por: Kim, Min, et al.
Publicado: (2019) -
Ablation and antiarrhythmic drug effects on PITX2(+/−) deficient atrial fibrillation: A computational modeling study
por: Jin, Ze, et al.
Publicado: (2022) -
Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs
por: Park, Yoon Jung, et al.
Publicado: (2023) -
Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
por: Choi, Ju Hee, et al.
Publicado: (2022) -
Lower pulmonary vein-to-left atrium volume ratio predicts poor rhythm outcome after atrial fibrillation catheter ablation
por: Lee, Jae-Hyuk, et al.
Publicado: (2022)